1.Malignant biliary obstruction treated with preoperative endoscopic ultrasound-guided hepaticogastrostomy: A case report
Taira KURODA ; Hideki MIYATA ; Yuka KIMURA ; Ayaka NAKAMURA ; Takuya MATSUDA ; Kana MATSUOKA ; Mai FUKUMOTO ; Kazuya MURAKAWA ; Taisei MURAKAMI ; Hirofumi IZUMOTO ; Kei ONISHI ; Shogo KITAHATA ; Kozue KANEMITSU-OKADA ; Tomoe KAWAMURA ; Fujimasa TADA ; Eiji TSUBOUCHI ; Jun HANAOKA ; Atsushi HIRAOKA ; Tomoyuki NINOMIYA
International Journal of Gastrointestinal Intervention 2025;14(1):20-23
We present the case of a 76-year-old man who underwent preoperative endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) for obstructive jaundice caused by pancreatic head cancer. The patient had obstructive jaundice and cholangitis during neoadjuvant chemotherapy. Transpapillary biliary drainage using endoscopic retrograde cholangiopancreatography was attempted; however, it was unsuccessful because of duodenal tumor invasion. Therefore, EUS-HGS was performed. Jaundice and cholangitis improved promptly after EUS-HGS, and stent obstruction and migration were not observed before surgery. The stent was safely removed during surgery, and no postoperative complications occurred. Most studies of EUS-HGS for preoperative biliary drainage have been small and retrospective, and few have examined the safety of intraoperative stent removal. The fistula in our patient was promptly identified and the stent was safely removed despite the relatively limited field of view during robot-assisted laparoscopy.The promising findings of our case report can be used to inform EUS-based surgical strategies for biliary drainage with obstructive jaundice.
2.A Systematic Review and Meta-Analysis of Systemic Corticosteroids for the Palliation of Dyspnea in Patients with Cancer
Kozue SUZUKI ; Hideki KATAYAMA ; Hiroyuki KOHARA ; Yoshinobu MATSUDA ; Sho GOYA ; Jun KAKO ; Yoko KASAHARA ; Masanori MORI ; Takeo NAKAYAMA ; Hiroaki WATANABE ; Takashi YAMAGUCHI
Palliative Care Research 2025;20(2):95-102
Objective: Almost half of all patients with cancer experience dyspnea, which can have various causes. Although systemic corticosteroids are administered to relieve symptoms, their efficacy has not been established. This systematic review aims to determine the efficacy of systemic corticosteroids for dyspnea in patients with cancer. Methods: CENTRAL, MEDLINE, EMBASE, and Ichushi-Web databases were searched for articles published from their inception to September 23, 2019, on studies of systemic corticosteroid administration for dyspnea in patients with cancer. The primary outcome measure was dyspnea intensity, as assessed by patient-reported outcomes. Secondary outcome measures were quality of life, delirium, and severe adverse events. Results: Two RCTs were included in the meta-analysis. With regard to alleviating dyspnea, the systematic corticosteroid group was associated with significantly greater dyspnea relief than the placebo group (mean difference: −0.71 [95% CI: −1.4 to −0.03]). However, a meta-analysis of quality of life and delirium could not be performed due to insufficient data. Analysis of severe adverse events showed no significant difference in their incidence between the corticosteroid and control groups (relative rate: 0.96 [95% CI: 0.19-4.93]). Conclusions: Systemic corticosteroids may be effective in treating dyspnea in patients with cancer, particularly those with lung involvement. Limiting the conditions for which corticosteroids are approved is expected to promote their appropriate use and minimize their adverse effects. However, further investigation is needed to determine the appropriate dosage, and the conditions in which corticosteroids are effective.
3.Malignant biliary obstruction treated with preoperative endoscopic ultrasound-guided hepaticogastrostomy: A case report
Taira KURODA ; Hideki MIYATA ; Yuka KIMURA ; Ayaka NAKAMURA ; Takuya MATSUDA ; Kana MATSUOKA ; Mai FUKUMOTO ; Kazuya MURAKAWA ; Taisei MURAKAMI ; Hirofumi IZUMOTO ; Kei ONISHI ; Shogo KITAHATA ; Kozue KANEMITSU-OKADA ; Tomoe KAWAMURA ; Fujimasa TADA ; Eiji TSUBOUCHI ; Jun HANAOKA ; Atsushi HIRAOKA ; Tomoyuki NINOMIYA
International Journal of Gastrointestinal Intervention 2025;14(1):20-23
We present the case of a 76-year-old man who underwent preoperative endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) for obstructive jaundice caused by pancreatic head cancer. The patient had obstructive jaundice and cholangitis during neoadjuvant chemotherapy. Transpapillary biliary drainage using endoscopic retrograde cholangiopancreatography was attempted; however, it was unsuccessful because of duodenal tumor invasion. Therefore, EUS-HGS was performed. Jaundice and cholangitis improved promptly after EUS-HGS, and stent obstruction and migration were not observed before surgery. The stent was safely removed during surgery, and no postoperative complications occurred. Most studies of EUS-HGS for preoperative biliary drainage have been small and retrospective, and few have examined the safety of intraoperative stent removal. The fistula in our patient was promptly identified and the stent was safely removed despite the relatively limited field of view during robot-assisted laparoscopy.The promising findings of our case report can be used to inform EUS-based surgical strategies for biliary drainage with obstructive jaundice.
4.Malignant biliary obstruction treated with preoperative endoscopic ultrasound-guided hepaticogastrostomy: A case report
Taira KURODA ; Hideki MIYATA ; Yuka KIMURA ; Ayaka NAKAMURA ; Takuya MATSUDA ; Kana MATSUOKA ; Mai FUKUMOTO ; Kazuya MURAKAWA ; Taisei MURAKAMI ; Hirofumi IZUMOTO ; Kei ONISHI ; Shogo KITAHATA ; Kozue KANEMITSU-OKADA ; Tomoe KAWAMURA ; Fujimasa TADA ; Eiji TSUBOUCHI ; Jun HANAOKA ; Atsushi HIRAOKA ; Tomoyuki NINOMIYA
International Journal of Gastrointestinal Intervention 2025;14(1):20-23
We present the case of a 76-year-old man who underwent preoperative endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) for obstructive jaundice caused by pancreatic head cancer. The patient had obstructive jaundice and cholangitis during neoadjuvant chemotherapy. Transpapillary biliary drainage using endoscopic retrograde cholangiopancreatography was attempted; however, it was unsuccessful because of duodenal tumor invasion. Therefore, EUS-HGS was performed. Jaundice and cholangitis improved promptly after EUS-HGS, and stent obstruction and migration were not observed before surgery. The stent was safely removed during surgery, and no postoperative complications occurred. Most studies of EUS-HGS for preoperative biliary drainage have been small and retrospective, and few have examined the safety of intraoperative stent removal. The fistula in our patient was promptly identified and the stent was safely removed despite the relatively limited field of view during robot-assisted laparoscopy.The promising findings of our case report can be used to inform EUS-based surgical strategies for biliary drainage with obstructive jaundice.
5.A case report with the coincidental complication of paroxysmal atrial fibrillation in the course of methadone administration due to cancer pain
Yoshinobu Matsuda ; Yoshito Yoshikawa ; Sachiko Okayama ; Rie Hiyoshi ; Kaori Tohno ; Momoyo Hashimoto ; Hideki Noma ; Mamoru Ohnishi ; Takayasu Itakura ; Sachiko Kimura ; Shun Kohsaka
Palliative Care Research 2016;11(1):501-505
Introduction: Paroxysmal atrial fibrillation (Paf) occurred in an inpatient who has been prescribed methadone for cancer pain in our palliative care unit, but oral administration of aprindine (antiarrhythmic agent) succeeded in defibrillation and methadone administration could be continued. Case: A 75-year-old man had developed multiple bone metastases after resection of thyroid cancer. Due to refractory cancer pain, switching from oxycodone to methadone was performed. Pain relief was achieved with methadone 40 mg/day and without QT interval prolongation. After methadone administration about 9 months, there suddenly became loss of appetite in the morning of one day. ECG examination revealed Paf onset. Aprindine 20 mg was orally administered for the purpose of defibrillation. After about 2 hours sinus rhythm was gained and later without recurrence. Conclusion: This case was considered to have the coincidental complication of paroxysmal atrial fibrillation in the course of methadone administration. If administration of antiarrhythmic agents is performed in a patient whom has been prescribed methadone, it is feared to lead to result in QT interval prolongation due to drug interactions. It is important to carefully select an agent that rarely leads to QT prolongation.
6.Microendoscopic Excision of Osteoid Osteoma in the Pedicle of the Third Lumbar Vertebra.
Katsuhito YOSHIOKA ; Eizo MATSUDA ; Hideki MURAKAMI ; Hiroyuki TSUCHIYA
Asian Spine Journal 2015;9(6):958-961
We present a rare case of a patient who underwent complete microendoscopic excision of an osteoid osteoma, which induced radiculopathy without nerve root compression. A 20-year-old man presented severe right groin pain that was temporarily relieved by nonsteroidal anti-inflammatory drugs. A computed tomography (CT) scan showed typical features of a nidus located in the inferior cortex of the right L3 pedicle. We performed surgery using a posterior microendoscopic approach. We drilled vertically along the line of the cortex of the caudal pedicle using a high-speed drill. After identifying the tumor, en bloc resection of the nidus was achieved. Immediately after surgery, pain in the right groin disappeared. A CT scan showed that most of the right L3 pedicle remained. This minimally invasive technique preserves spinal structures, including the facet and pedicle, and is a viable option for the treatment of spinal osteoid osteomas located close to vital structures.
Groin
;
Humans
;
Osteoma, Osteoid*
;
Radiculopathy
;
Spine*
;
Tomography, X-Ray Computed
;
Young Adult
7.A Retrospective Analysis of the 44 Cases with Opioid Switching to Methadone
Sachiko Kimura ; Yoshinobu Matsuda ; Kozue Yoshida ; Rie Hiyoshi ; Kaori Tohno ; Sachiko Okayama ; Hideki Noma ; Takayasu Itakura
Palliative Care Research 2015;10(3):194-200
Purpose:Methadone is an opioid used in Japan for the treatment of cancer pain. A thorough consideration of complex pharmacokinetics with individual differences and of serious adverse effects is necessary before switching to methadone; therefore, methadone is not yet widely used. We examined the analgesic and adverse effects of methadone through clinical cases and considered the clinical significance of methadone as an opioid analgesic for the treatment of cancer pain. Methods:The clinical course of 44 patients with cancer pain who were switched to methadone from other opioids was analyzed. Results:Out of the 44 cases investigated, 37 cases (84.1%) were successful. In the successful cases, pain intensity before and after methadone administration was reduced from an average of 7.5 to 2.8, respectively, on the numerical rating scale. Strong drowsiness (six cases) and nausea (three cases) were observed as adverse effects. However, no serious effects, such as QT prolongation and respiratory depression, were recognized. Conclusion:For patients with refractory cancer pain who require a high opioid dose, methadone is considered to be one of the alternatives in pain therapeutics.
8.A retrospective analysis of patients who were switched from methadone to a different opioid: How to treat cancer pain after patients become unable to take methadone orally at the end of life
Takayasu Itakura ; Yoshinobu Matsuda ; Sachiko Okayama ; Kaori Tohno ; Rie Hiyoshi ; Kozue Yoshida ; Sachiko Kimura ; Hideki Noma
Palliative Care Research 2015;10(4):245-250
Background: Methadone can only be administered orally in Japan. However, it is unclear how to treat pain when patients become unable to take methadone orally because of the progression of the disease. Aims: To assess retrospectively end-of-life pain control management after patients become unable to take methadone orally. Methods: Twenty-eight patients with cancer pain undergoing treatment with oral methadone died at a palliative care unit between April 2013 and September 2014. All patients died of cancer and were unable to swallow before death. We assessed pain control approaches after the patients became unable to take methadone orally. Results: Twenty-one patients survived 1 day or longer after becoming unable to swallow. Methadone was switched to another opioid because of pain. Of these 21 patients, 10 patients survived for 1 week or longer after being switched to another opioid. At this point, methadone would be mostly eliminated from the blood circulation. Among these 10 patients, seven patients were treated with subcutaneous morphine, and three patients were excluded because their pain could not be evaluated. The conversion ratio from final oral methadone dosage to oral morphine equivalent dose of opioids used on the seventh day was 6.1. Conclusion: Even when patients become unable to ingest methadone, switching to other opioids may not always be necessary because of the long half-life of methadone when pain is absent at the end of life. If necessary, pain could be managed by switching to other opioids with a conversion ratio of 6.1.
9.The association of the number of comorbidities and complications with length of stay, hospital mortality and LOS high outlier, based on administrative data.
Kazuaki KUWABARA ; Yuichi IMANAKA ; Shinya MATSUDA ; Kiyohide FUSHIMI ; Hideki HASHIMOTO ; Koichi B ISHIKAWA ; Hiromasa HORIGUCHI ; Kenshi HAYASHIDA ; Kenji FUJIMORI
Environmental Health and Preventive Medicine 2008;13(3):130-137
OBJECTIVESWith greater concern for efficient resource allocation and profiling of medical care, a case-mix classification was applied for the per-diem payment system in Japan. Many questions remain, one of which is the role of comorbidity and complication (CC) in grouping logic. We examined the association of the number of CC with the length of hospital stay (LOS) and hospital mortality as well as the proportion of LOS high outliers in 19 major diagnostic categories (MDCs).
METHODSThis study was a secondary data analysis embedded in a government research project, including anonymous claims and clinical data during a 4-month period from July 2002. Every 19 MDC, LOS, hospital mortality or proportion of LOS high outliers was compared by the number of CC and presence of any procedures.
RESULTSFrom 82 special function hospitals, 241,268 patients were enrolled in this study. Among all patients, 50.5% were identified without any CCs, 32.4% with one or two, 13.4% with three or four, and 3.7% with over five CCs. The overall mean LOS was 22.15 days and hospital mortality 26.05 cases per 1,000 admissions. In any MDC, LOS and the proportion of outliers increased as the number of CC rose. The mortality rate increased prominently in the respiratory system and the hematology system.
CONCLUSIONSThis study demonstrated that the occurrence of more CC caused longer LOS and higher mortality in some major disease categories. Further study will clarify the association of the weighted CC with resource use through controlling procedures specific for MDC.
10.A Case of Endovascular Stent Graft Placement for a Proximal Anastomotic Aneurysm after Abdominal Aortic Aneurysm Surgery
Munehiro Saiki ; Hideki Nakashima ; Tohru Hiroe ; Yoshinobu Nakamura ; Naruto Matsuda ; Yasushi Kanaoka ; Shingo Ishiguro ; Shigetsugu Ohgi
Japanese Journal of Cardiovascular Surgery 2005;34(6):406-408
A 77-year-old man was hospitalized for a proximal anastomotic aneurysm 9 years after surgery for an abdominal aortic aneurysm. The aneurysm was located 3cm distal to the renal artery. The maximum diameter was 55mm. His medical history included a reoperation for the proximal anastomotic aneurysm and cerebral infarction. Endovascular stent grafting was performed because it was possible anatomically. Postoperatively, no endoleak nor migration were found. At present, the patient is being followed up regularly in the outpatient department. Endovascular stent graft placement can be an effective method for reoperation cases of an abdominal aortic aneurysm, and if it is possible anatomically, it should be attempted.


Result Analysis
Print
Save
E-mail